DK0715624T3 - Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin - Google Patents
Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrinInfo
- Publication number
- DK0715624T3 DK0715624T3 DK94924368T DK94924368T DK0715624T3 DK 0715624 T3 DK0715624 T3 DK 0715624T3 DK 94924368 T DK94924368 T DK 94924368T DK 94924368 T DK94924368 T DK 94924368T DK 0715624 T3 DK0715624 T3 DK 0715624T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- gastrin
- cck
- date
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Fats And Perfumes (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Lubricants (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9317693A GB2282595A (en) | 1993-08-25 | 1993-08-25 | Benzodiazepine derivatives |
| PCT/GB1994/001859 WO1995006040A1 (fr) | 1993-08-25 | 1994-08-25 | Composes de benzodiazepine utilises comme antagonistes de la cck ou de la gastrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0715624T3 true DK0715624T3 (da) | 1999-01-11 |
Family
ID=10741026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94924368T DK0715624T3 (da) | 1993-08-25 | 1994-08-25 | Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5728829A (fr) |
| EP (1) | EP0715624B1 (fr) |
| JP (1) | JPH09504005A (fr) |
| KR (1) | KR960703873A (fr) |
| CN (1) | CN1129442A (fr) |
| AT (1) | ATE164840T1 (fr) |
| AU (1) | AU687433B2 (fr) |
| CA (1) | CA2169089A1 (fr) |
| CZ (1) | CZ53096A3 (fr) |
| DE (1) | DE69409534T2 (fr) |
| DK (1) | DK0715624T3 (fr) |
| ES (1) | ES2117797T3 (fr) |
| FI (1) | FI960836A (fr) |
| GB (1) | GB2282595A (fr) |
| HU (1) | HUT73978A (fr) |
| IL (1) | IL110783A0 (fr) |
| NO (1) | NO960747L (fr) |
| NZ (1) | NZ271131A (fr) |
| PL (1) | PL313165A1 (fr) |
| WO (1) | WO1995006040A1 (fr) |
| ZA (1) | ZA946474B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9903330A2 (hu) | 1996-11-19 | 2000-03-28 | Amgen Inc. | Gyulladásgátló hatású, aril- és heteroaril csoporttal szubsztituált kondenzált pirrolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények |
| WO1998025911A1 (fr) * | 1996-12-10 | 1998-06-18 | Zeria Pharmaceutical Co., Ltd. | Derives de 1,5-benzodiazepine |
| FR2782997A1 (fr) * | 1998-09-08 | 2000-03-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la benzodiazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicaments et compositions pharmaceutiques les renfermant |
| US20040138207A1 (en) * | 2001-05-11 | 2004-07-15 | Mayumi Yamano | Antitumor agents |
| GB0221923D0 (en) * | 2002-09-20 | 2002-10-30 | Arrow Therapeutics Ltd | Chemical compounds |
| AU2004252150B2 (en) * | 2003-06-26 | 2008-11-20 | Merck Sharp & Dohme Corp. | Benzodiazepine CGRP receptor antagonists |
| US8053413B2 (en) * | 2005-06-06 | 2011-11-08 | The Board Of Trustees Of The University Of Illinois | Methods for treating sleep disorders by cholecystokinin (CCK) receptor B antagonists |
| JP6502939B2 (ja) | 2013-11-22 | 2019-04-17 | シーエル バイオサイエンシズ リミティド ライアビリティ カンパニー | 骨粗鬆症の処置及び予防のためのガストリン拮抗薬 |
| GB201414116D0 (en) * | 2014-08-08 | 2014-09-24 | Trio Medicines Ltd | Benzodiazepine derivatives |
| GB201513979D0 (en) | 2015-08-07 | 2015-09-23 | Trio Medicines Ltd | Synthesis of benzodiazepine derivatives |
| US10881667B2 (en) | 2018-10-30 | 2021-01-05 | City University Of Hong Kong | Method and composition for treating epilepsy |
| CN109553591B (zh) * | 2019-01-15 | 2020-12-15 | 山东安信制药有限公司 | 一种富马酸喹硫平中间体的制备方法 |
| US11285161B2 (en) | 2019-04-26 | 2022-03-29 | City University Of Hong Kong | Method and composition for treating mental disorder and pain associated with nerve damage |
| FR3097222B1 (fr) * | 2019-06-11 | 2021-05-28 | Michelin & Cie | Nouveaux composes 1,3-dipolaires comprenant un heterocycle aromatique et un cycle imidazole |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
| IL96613A0 (en) * | 1989-12-18 | 1991-09-16 | Merck & Co Inc | Pharmaceutical compositions containing benzodiazepine analogs |
| HUT67299A (en) * | 1990-12-25 | 1995-03-28 | Yamanouchi Pharma Co Ltd | Novel benzodiazepine derivetives, pharmaceutical compositions contaning them and process for their producing |
| GB9116113D0 (en) * | 1991-07-25 | 1991-09-11 | Merck Sharp & Dohme | Therapeutic agents |
| FR2682381B1 (fr) * | 1991-10-10 | 1995-04-07 | Rhone Poulenc Rorer Sa | Derives de benzodiazepine, leur preparation et les medicaments les contenant. |
| WO1993007131A1 (fr) * | 1991-10-10 | 1993-04-15 | Merck Sharp & Dohme Limited | Derives de benzodiazepine et leur utilisation comme antagonistes de recepteurs de cholecystokinine et/ou de gastrine |
| WO1993008175A1 (fr) * | 1991-10-24 | 1993-04-29 | Glaxo Group Limited | Derives de benzodiazepine utilises comme antagonistes de la gastrine et/ou de la cholecystokinine |
| IL104853A (en) * | 1992-02-27 | 1997-11-20 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them |
| GB2264492B (en) * | 1992-02-27 | 1996-09-25 | Yamanouchi Pharma Co Ltd | Benzodiazepine derivatives |
| WO1994000438A1 (fr) * | 1992-06-24 | 1994-01-06 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive de benzodiazepine |
-
1993
- 1993-08-25 GB GB9317693A patent/GB2282595A/en not_active Withdrawn
-
1994
- 1994-08-25 ES ES94924368T patent/ES2117797T3/es not_active Expired - Lifetime
- 1994-08-25 AT AT94924368T patent/ATE164840T1/de active
- 1994-08-25 DE DE69409534T patent/DE69409534T2/de not_active Expired - Lifetime
- 1994-08-25 US US08/591,567 patent/US5728829A/en not_active Expired - Lifetime
- 1994-08-25 CZ CZ96530A patent/CZ53096A3/cs unknown
- 1994-08-25 ZA ZA946474A patent/ZA946474B/xx unknown
- 1994-08-25 JP JP7507439A patent/JPH09504005A/ja active Pending
- 1994-08-25 CA CA002169089A patent/CA2169089A1/fr not_active Abandoned
- 1994-08-25 NZ NZ271131A patent/NZ271131A/en not_active IP Right Cessation
- 1994-08-25 AU AU74661/94A patent/AU687433B2/en not_active Ceased
- 1994-08-25 PL PL94313165A patent/PL313165A1/xx unknown
- 1994-08-25 EP EP94924368A patent/EP0715624B1/fr not_active Expired - Lifetime
- 1994-08-25 CN CN94193134A patent/CN1129442A/zh active Pending
- 1994-08-25 KR KR1019960700905A patent/KR960703873A/ko not_active Application Discontinuation
- 1994-08-25 HU HU9600205A patent/HUT73978A/hu unknown
- 1994-08-25 IL IL11078394A patent/IL110783A0/xx unknown
- 1994-08-25 WO PCT/GB1994/001859 patent/WO1995006040A1/fr not_active Application Discontinuation
- 1994-08-25 DK DK94924368T patent/DK0715624T3/da active
-
1996
- 1996-02-23 FI FI960836A patent/FI960836A/fi unknown
- 1996-02-23 NO NO960747A patent/NO960747L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE164840T1 (de) | 1998-04-15 |
| FI960836A (fi) | 1996-04-22 |
| AU687433B2 (en) | 1998-02-26 |
| WO1995006040A1 (fr) | 1995-03-02 |
| KR960703873A (ko) | 1996-08-31 |
| NO960747L (no) | 1996-04-25 |
| US5728829A (en) | 1998-03-17 |
| HUT73978A (en) | 1996-10-28 |
| PL313165A1 (en) | 1996-06-10 |
| DE69409534D1 (de) | 1998-05-14 |
| EP0715624B1 (fr) | 1998-04-08 |
| EP0715624A1 (fr) | 1996-06-12 |
| IL110783A0 (en) | 1994-11-11 |
| DE69409534T2 (de) | 1998-08-06 |
| FI960836A0 (fi) | 1996-02-23 |
| ZA946474B (en) | 1996-03-25 |
| HU9600205D0 (en) | 1996-04-29 |
| CA2169089A1 (fr) | 1995-03-02 |
| CN1129442A (zh) | 1996-08-21 |
| CZ53096A3 (en) | 1996-09-11 |
| GB9317693D0 (en) | 1993-10-13 |
| GB2282595A (en) | 1995-04-12 |
| AU7466194A (en) | 1995-03-21 |
| NZ271131A (en) | 1997-11-24 |
| ES2117797T3 (es) | 1998-08-16 |
| NO960747D0 (no) | 1996-02-23 |
| JPH09504005A (ja) | 1997-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0715624T3 (da) | Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin | |
| ES2119160T3 (es) | Derivados de tiazolidina, su preparacion y los medicamentos que les contienen. | |
| ATE235470T1 (de) | Gastrin- und cck-antagonisten | |
| KR20000057506A (en) | 1,5-benzodiazepine derivatives | |
| DE69828445D1 (de) | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| FI962494A0 (fi) | 5-(2-imidatsolinyyliamino)bentsimidatsolijohdannaisia, niiden valmistus ja niiden käyttö alpha-2-adrenoseptoriagonisteina | |
| MX9205817A (es) | Derivados de benzodiazepina, procedimiento para supreparacion y medicamentos que los contienen | |
| SE8505715D0 (sv) | Indolderivat | |
| RU94038255A (ru) | Производные бензодиазепина, способ их получения, фармацевтическая композиция | |
| IL113365A0 (en) | 5-heterocyclo-1,5-benzodiazepine derivatives, their preparation and use and pharmaceutical compositions containing them | |
| FI803237L (fi) | 6,7-bensomorfanderivat foerfaranden foer deras framstaellning farmaceutiska sammansaettningar innehaollande naemnda derivat och deras anvaendning som laekemedel | |
| PT813411E (pt) | Utilizacao de derivados de vinpocetina para inibicao da producao ou da secrecao de proteina amiloide beta | |
| TW221993B (fr) | ||
| GB9318790D0 (en) | Heterocyclic derivatives | |
| DE3266521D1 (en) | 2-acylaminomethyl-1,4-benzodiazepine derivatives, their preparation and intermediates, and pharmaceutical preparations containing them | |
| DE69334353D1 (de) | Benzodiazepin-Derivate, verwendbar als CCK-Rezeptor Antagonisten | |
| ATE49601T1 (de) | Neue 11-piperazinyl-5h-imidazo(2,1c>(1,4>benzodiazepine, verfahren zu ihrer herstellung und zwischenprodukte und erstere enthaltende arzneimittel. | |
| ATE67760T1 (de) | In stellung 2 substituierte monoaryl-5 astriazinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| DK573981A (da) | Fremgangsmaade til fremstilling af cis-c-3",c4"-carbonatderivater af o-demethyl-oleandomycin og mellemprodukter herfor | |
| TH18598A (th) | อนุพันธ์ 1,5-เบนโซไดอะเซฟีน | |
| TH18598EX (th) | อนุพันธ์ 1,5-เบนโซไดอะเซฟีน |